Eribulin EVER Pharma 0,44 mg/ml otopina za injekciju
Name | Eribulin EVER Pharma 0,44 mg/ml otopina za injekciju |
---|---|
Marketing Authorisation Number | HR-H-870080195 |
Active Substance | eribulinmesilat |
Composition | jedan ml otopine sadrži 0,44 mg eribulina u obliku eribulinmesilata jedna bočica od 2 ml sadrži 0,88 mg eribulina u obliku eribulinmesilata jedna bočica od 3 ml sadrži 1,32 mg eribulina u obliku eribulinmesilata |
Pharmaceutical Form | otopina za injekciju |
Manufacturer | oncomed manufacturing a.s., Brno-Rečkovice, Češka
Ever Pharma Jena GmbH, Jena, Njemačka |
Marketing Authorisation Holder | EVER Valinject GmbH, Oberburgau 3, Unterach am Attersee, Austrija |
Marketing Authorisation Date | 09.05.2024 |
MA Period of Validity | 09.05.2029 |
Classification Number | UP/I-530-09/22-01/296 |
Registration Number | 381-12-01/70-24-08 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | L01XX41 |
SmPC | download |
PL | download |
Public Assessment Report | download |